GlassScriptPhysician profile
Travis Thomas Baes
NPI 1720574874
$6,611.10
in general payments reported to CMS, 2019-2025
13 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $237 · 2021: $30.75 · 2022: $555 · 2023: $1,081 · 2024: $3,321 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,401 · Food and Beverage: $1,756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,400.68 |
| Food and Beverage | $1,755.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,314.57 | 2020-2025 | Blueprint Patient Specific Instrumentation, 1788, Iconix |
| Anika Therapeutics, INC. | $999.26 | 2023 | Ovomotion, Drawtight, X-Twist |
| Medwest Associates | $462.42 | 2019 | |
| Zimmer Biomet Holdings, INC. | $280.30 | 2019-2024 | Genex, Tapestry, Juggerstitch |
| Depuy Synthes Sales INC. | $152.61 | 2020-2023 | Na |
| Sanara Medtech INC. | $101.68 | 2025 | Celleraterx |
| Si-Bone, INC. | $100.74 | 2022 | |
| Kci USA, INC. | $61.76 | 2019 | |
| Pinnacle, INC | $34.60 | 2023 | |
| Axogen | $30.75 | 2021 | |
| Solventum Corporation | $25.26 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Fx Shoulder Solutions, INC | $24.99 | 2019 | |
| Acumed LLC | $22.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Baes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.